Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients

Introduction: Antibody-mediated rejection (ABMR) impacts kidney allograft outcome. The diagnosis is made based on findings from invasive kidney transplant biopsy specimens. The aim of this study was to identify a noninvasive urinary protein biomarker for ABMR after kidney transplantation. Methods: W...

Full description

Bibliographic Details
Main Authors: Inge Mertens, Hanny Willems, Elisabet Van Loon, Karin Schildermans, Kurt Boonen, Geert Baggerman, Dirk Valkenborg, Wilfried Gwinner, Dany Anglicheau, Marie Essig, Pierre Marquet, Maarten Naesens
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Kidney International Reports
Subjects:
antibody-mediated rejection
noninvasive biomarker
renal transplantation
urinary proteomics
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024920313413

Internet

http://www.sciencedirect.com/science/article/pii/S2468024920313413

Similar Items